Joan Bargay Selected Research

Joan Bargay Research Topics

Disease

23	Multiple Myeloma 12/2023 - 01/2002
11	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 09/2002
8	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 04/2018 - 09/2002
6	Neoplasms (Cancer) 01/2023 - 08/2016
4	Lymphoma (Lymphomas) 04/2018 - 12/2014
3	Infections 10/2023 - 08/2016
3	Smoldering Multiple Myeloma 10/2022 - 08/2013
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022 - 06/2016
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2016 - 10/2013
2	Circulating Neoplastic Cells 11/2022 - 01/2022
2	Neutropenia 11/2020 - 08/2016
2	Disease Progression 01/2020 - 09/2002
2	Hodgkin Disease (Hodgkin's Disease) 01/2020 - 01/2014
2	Residual Neoplasm 01/2019 - 12/2013
2	Leukemia 10/2018 - 09/2002
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 10/2017 - 12/2014
2	Pathologic Complete Response 11/2014 - 10/2010
2	Chromosome Aberrations (Chromosome Abnormalities) 10/2011 - 04/2008
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2011 - 05/2003
1	Genomic Instability 01/2021
1	Anemia 11/2020
1	Fatigue 04/2018
1	Asthenia 08/2016
1	Exanthema (Rash) 08/2016
1	Bone Diseases (Bone Disease) 09/2015
1	Hematologic Neoplasms (Hematological Malignancy) 12/2013
1	Hematologic Diseases (Blood Diseases) 12/2013
1	Melanoma (Melanoma, Malignant) 12/2013
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2010
1	Splenic Rupture 08/2004
1	Body Weight (Weight, Body) 08/2003
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 05/2003
1	Graft vs Host Disease (Graft-Versus-Host Disease) 07/2002

Drug/Important Bio-Agent (IBA)

7	Bortezomib (Velcade)FDA Link 01/2016 - 10/2006
6	Dexamethasone (Maxidex)FDA LinkGeneric 10/2023 - 08/2013
6	Lenalidomide (CC 5013)FDA Link 10/2022 - 08/2013
6	Azacitidine (5 Azacytidine)FDA Link 04/2018 - 06/2014
6	Prednisone (Sone)FDA LinkGeneric 01/2016 - 10/2006
5	Biomarkers (Surrogate Marker)IBA 12/2023 - 04/2018
5	Melphalan (Alkeran)FDA LinkGeneric 01/2016 - 10/2006
4	Rituximab (Mabthera)FDA Link 01/2022 - 12/2014
3	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2020 - 08/2004
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2023 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2019
2	Nerve Growth Factor (NGF)IBA 01/2021 - 10/2020
2	AlbuminsIBA 11/2020 - 04/2008
2	Bendamustine Hydrochloride FDA Link 10/2017 - 12/2014
2	Thalidomide (Thalomid)FDA Link 09/2012 - 10/2010
1	Immunoglobulins (Immunoglobulin)IBA 11/2023
1	carfilzomibIBA 10/2023
1	midostaurinIBA 01/2023
1	Immunomodulating AgentsIBA 01/2023
1	5'-Nucleotidase (5' Nucleotidase)IBA 12/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	Serum AlbuminIBA 01/2022
1	ibritumomab tiuxetan (Zevalin)FDA Link 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	NivolumabIBA 01/2020
1	Vascular Endothelial Growth Factor CIBA 10/2018
1	Hemoglobins (Hemoglobin)IBA 04/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2016
1	Vincristine (Oncovin)FDA LinkGeneric 01/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016
1	MicroRNAs (MicroRNA)IBA 10/2015
1	Long Noncoding RNAIBA 10/2015
1	Zoledronic Acid (Zometa)FDA Link 09/2015
1	N 30IBA 11/2014
1	Alkylating AgentsIBA 09/2014
1	Gemcitabine FDA Link 01/2014
1	ribonucleotide polymeraseIBA 12/2013
1	pegfilgrastim (Neulasta)FDA Link 10/2013
1	DNA (Deoxyribonucleic Acid)IBA 10/2011
1	Imatinib Mesylate (Gleevec)FDA Link 09/2011
1	Diphosphonates (Bisphosphonates)IBA 03/2010
1	Erythropoietin FDA Link 02/2010
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 02/2010
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 04/2008
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2004
1	cyclo(Arg-Pro) (CI 4)IBA 09/2002

Therapy/Procedure

16	Therapeutics 01/2022 - 08/2004
4	Drug Therapy (Chemotherapy) 01/2023 - 06/2016
4	Stem Cell Transplantation 12/2013 - 01/2002
3	Transplantation 01/2020 - 01/2002
2	Consolidation Chemotherapy 11/2020 - 08/2004
2	Hematopoietic Stem Cell Transplantation 01/2020 - 05/2003
1	Immunotherapy 03/2016
1	Immunomodulation 03/2016
1	Blood Component Removal (Apheresis) 08/2003
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 09/2002